The two funds that the fund manager took over are both theme funds, and they are all leading stocks with heavy positions, that is, holding shares, and the disintegration of holding shares after the Spring Festival directly led to the sharp withdrawal of the fund's net value. Under the plunge, there are no winners, even star fund managers, such as Zhang Kun and Liu Yanchun. For the new fund manager, the situation is even worse. According to public information, the fund manager manages two medical theme funds. The positions of the two funds are similar, and they are also some industry leaders. There is nothing wrong with the choice, but the timing is wrong.

These leading stocks are also the core of the group's stocks. After a round of skyrocketing last year, the valuation of the group's shares has reached its peak. As a result, as soon as the Year of the Ox opened, the share price of Baotuan plummeted, and the funds that had invested heavily in these stocks also showed a huge retreat. It can only be said that the fund manager did not choose a good time and still held these white horse stocks at the peak, which naturally faced great risks.

However, with the gradual recovery of A-shares in recent days, the white horse stocks that plunged earlier also began to rise, and the fund income was also red. In the long run, this round of adjustment has basically ended, and some white horse stocks have shown investment value space. This is also the best time for investors to add positions.

References:

According to public information, Meng Yuan graduated from Peking University with a bachelor's degree and graduated from the University of Reading with a master's degree. He has six years of experience in securities industry. He has served as a researcher of Bank of China Fund and assistant to the manager of Agricultural Bank of China Huili Fund. Since February 24 this year, he has been a fund manager, managing products.

Meng Yuan took over two funds, namely, Agricultural Bank of China Health Care Theme Fund and Agricultural Bank of China Huili Innovative Medical Care Fund, which were established in February 20 15 and June 2020 respectively, with a total scale of 4.747 billion yuan. Judging from the positions, when Zhao Wei, the last fund manager, took over, the heavyweight stocks of the two funds were highly consistent, mostly white horse stocks of Mindray Medical, Shi Yao Science and Technology, Aier Ophthalmology and Wuxi PharmaTech, and some well-known stocks in the market.